Table 3 Collaboration between Arab countries and non-Arab countries in leishmaniasis research during 1998–2017
From: Arab world’s growing contribution to global leishmaniasis research (1998–2017): a bibliometric study
Country | Number of documents | % | Country | Number of documents | % |
|---|---|---|---|---|---|
France | 132 | 13.29 | Greece | 6 | 0.60 |
United States | 99 | 9.97 | Nepal | 6 | 0.60 |
United Kingdom | 88 | 8.86 | Colombia | 5 | 0.50 |
Germany | 51 | 5.14 | Czech Republic | 5 | 0.50 |
Belgium | 47 | 4.73 | Japan | 5 | 0.50 |
Netherlands | 43 | 4.33 | Nigeria | 4 | 0.40 |
Switzerland | 39 | 3.93 | Turkey | 4 | 0.40 |
India | 37 | 3.73 | Cuba | 3 | 0.30 |
Israel | 29 | 2.92 | Russian Federation | 3 | 0.30 |
Spain | 24 | 2.42 | South Africa | 3 | 0.30 |
Kenya | 23 | 2.32 | Austria | 2 | 0.20 |
Brazil | 20 | 2.01 | Ghana | 2 | 0.20 |
Ethiopia | 17 | 1.71 | Luxembourg | 2 | 0.20 |
Pakistan | 17 | 1.71 | Malaysia | 2 | 0.20 |
Italy | 15 | 1.51 | Uzbekistan | 2 | 0.20 |
Canada | 14 | 1.41 | Venezuela | 2 | 0.20 |
Sweden | 14 | 1.41 | Albania | 1 | 0.10 |
Denmark | 13 | 1.31 | Burkina Faso | 1 | 0.10 |
Uganda | 12 | 1.21 | Congo | 1 | 0.10 |
Iran | 10 | 1.01 | Croatia | 1 | 0.10 |
Australia | 9 | 0.91 | Ecuador | 1 | 0.10 |
Malawi | 9 | 0.91 | Guatemala | 1 | 0.10 |
Portugal | 9 | 0.91 | Hong Kong | 1 | 0.10 |
Bangladesh | 7 | 0.70 | Mexico | 1 | 0.10 |
Peru | 7 | 0.70 | Singapore | 1 | 0.10 |
China | 6 | 0.60 | Thailand | 1 | 0.10 |